Edition:
India

Ritter Pharmaceuticals Inc (RTTR.OQ)

RTTR.OQ on NASDAQ Stock Exchange Capital Market

2.97USD
10:08pm IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.97
Open
$2.96
Day's High
$3.00
Day's Low
$2.91
Volume
1,494
Avg. Vol
19,850
52-wk High
$7.48
52-wk Low
$1.90

Chart for

About

Ritter Pharmaceuticals, Inc. develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company's segment is focusing on the development and commercialization of RP-G28. The Company conducts human gut health research by exploring metabolic capacity of the gut microbiota and... (more)

Overall

Beta: --
Market Cap(Mil.): $5.57
Shares Outstanding(Mil.): 14.76
Dividend: --
Yield (%): --

Financials

BRIEF-Ritter Pharmaceuticals Announces 1-For-10 Reverse Stock Split

* RITTER PHARMACEUTICALS ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

22 Mar 2018

BRIEF-Ritter Pharmaceuticals Reports Q4 Loss Per Share $0.11

* RITTER PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

19 Mar 2018

BRIEF-Ritter Pharmaceuticals Reports Microbiome Data From Phase 2B Study Of RP-G28 Promotes Beneficial Adaptation Of The Gut Microbiome

* RITTER PHARMACEUTICALS REPORTS MICROBIOME DATA FROM PHASE 2B STUDY OF RP-G28 PROMOTES BENEFICIAL ADAPTATION OF THE GUT MICROBIOME

12 Mar 2018

BRIEF-Ritter Pharma Board Approves 1-For-10 Reverse Stock Split

* RITTER PHARMACEUTICALS, INC.’S BOARD APPROVES 1-FOR-10 REVERSE STOCK SPLIT Source text for Eikon: Further company coverage:

02 Mar 2018

Earnings vs. Estimates